Clinical Trial Update: Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is planned to evaluate whether oral losartan can reduce postoperative scarring after anterior cruciate ligament reconstruction; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Injury
• Scar Formation

Drugs mentioned

• Cozaar (losartan)

Snippet

Sponsor: Rush University Medical Center | Conditions: ACL Injury, ACL Reconstruction | Phase 4 | Status: NOT_YET_RECRUITING